Cutaneous fusasriosis developing in a post-irradiation site

Dermatology Online Journal

Volumn 17, Issue 5, 2011, Pages

  Dai, Weiwei ^a   Dharamsi, Jennifer Warner ^b   Soliman, Sameer ^b   Ricotti, Carlos ^b   Gander, Rita ^b   Bergstresser, Paul ^b   Chan, Joanna ^b  

^a University Hospitals Richmond Medical Center   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; PREDNISONE; VORICONAZOLE;

ADULT; ANAMNESIS; ARTICLE; BACTERIAL INFECTION; CADAVER KIDNEY; CANCER RADIOTHERAPY; CASE REPORT; CHRONIC KIDNEY DISEASE; CUTANEOUS FUSARIOSIS; DEBRIDEMENT; FEMALE; FOLLOW UP; FUNGUS IDENTIFICATION; FUSARIOSIS; FUSARIUM; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSECT BITE; KIDNEY TRANSPLANTATION; MIXED CELL LYMPHOMA; PUNCH BIOPSY; RADIATION DERMATITIS; SKIN ULCER; STAINING; SUPERINFECTION; WOUND HEALING; ANEMIA; B CELL LYMPHOMA; DERMATOMYCOSIS; HUMAN TISSUE; KIDNEY ALLOGRAFT; KIDNEY DISEASE; LEG ULCER; MUSCLE FLAP; NONHUMAN; RADIATION INJURY; T CELL LYMPHOMA;

EID: 79960710902     PISSN: 10872108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Boutati EI, Anaissie EJ. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management. Blood. 1997 Aug 1;90(3):999-1008.[PubMed]
2. Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev. 2007 Oct;20(4):695-704.[PubMed]
3. Willemsen MJ, De Coninck AL, Coremans-Pelseneer JE, Marichal-Pipeleers MA, Roseeuw DI. Parasitic invasion of Fusarium oxysporum in an arterial ulcer in an otherwise healthy patient. Mykosen. 1986 Jun;29(6):248-52.[PubMed]
4. van Dijk E, van den Berg WH, Landwehr AJ. Fusarium solani infection of a hypertensive leg ulcer in a diabetic. Mykosen. 1980 Nov;23(11):603-6.[PubMed]
5. Jensen HE, Schonheyder HC, Hotchi M, Kaufman L. Diagnosis of systemic mycoses by specific immunohistochemical tests. APMIS. 1996 Apr;104(4):241-58.[PubMed]
6. Nucci M, Anaissie EJ, Queiroz-Telles F, Martins CA, Trabasso P, Solza C, Mangini C, Simoes BP, Colombo AL, Vaz J, Levy CE, Costa S, Moreira VA, Oliveira JS, Paraguay N, Duboc G, Voltarelli JC, Maiolino A, Pasquini R, Souza CA. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer. 2003 Jul 15;98(2):315-9.[PubMed]
7. Al-Badriyeh D, Heng SC, Neoh CF, Slavin M, Stewart K, Kong DC. Pharmacoeconomics of voriconazole in the management of invasive fungal infections. Expert Rev Pharmacoecon Outcomes Res. 2010 Dec;10(6):623-36.[PubMed]
8. Lortholary O, Obenga G, Biswas P, Caillot D, Chachaty E, Bienvenu AL, Cornet M, Greene J, Herbrecht R, Lacroix C, Grenouillet F, Raad I, Sitbon K, Troke P. International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole. Antimicrob Agents Chemother. 2010 Oct;54(10):4446-50.[PubMed]
9. Raad II, Hachem RY, Herbrecht R, Graybill JR, Hare R, Corcoran G, Kontoyiannis DP. Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions. Clin Infect Dis. 2006 May 15;42(10):1398-403.[PubMed]
10. Hymes SR, Strom EA, Fife C. Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006. J Am Acad Dermatol. 2006 Jan;54(1):28-46.[PubMed]